In this study, we aimed to evaluate the clinical significance of c-Rel nuclear expression and REL amplification in DLBCL patients, to gain insight into the underlying biology, c-Rel function, activation mechanisms, and relationship with other NF-κB subunits. The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.